FMO5 and metabolic dysfunction-associated steatotic liver disease: Moreover, metabolic liver diseases such as NAFLD are associated with increased ROS production during fatty acid β-oxidation, endoplasmic reticulum stress, and NADPH oxidase alterations [61].